Clinical Study
Medical and Interventional Therapy for Spontaneous Vertebral Artery Dissection in the Craniocervical Segment
Table 1
Summary of characteristics of the 14 patients with SVAD treated by stenting.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A: ataxia; N: nystagmus; T: tinnitus; V: vomiting; H: headache; P: neck pain; D&D: dysphagia and dysarthria; m: male; f: female; SVAD: spontaneous vertebral artery dissection; VA: vertebral artery; Devel of con-VA: development of contralateral vertebral artery distal to the orifice of PICA (posterior inferior cerebellar artery); NIHSS: National Institute of Health stroke scale; mRS: modified Rankin score; V3: the third segment of vertebral artery; V2: the second segment of vertebral artery; L: left; R: right; DoVA(+): dissection on the dominant vertebral artery; DoVA(−): dissection on the nondominant vertebral artery; HT: hypertension; FHS: family history of stroke; DM: diabetes mellitus. |